DURECT CORP (DRRX)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenues | 447 | 321 | 1,927 | |
| Selling, general and administrative | 2,067 | 2,577 | 3,217 | |
| Research and development | 1,176 | 1,883 | 2,164 | |
| Cost of product revenues | 7 | - | 513 | |
| Total operating expenses | 3,250 | 4,460 | 5,894 | |
| Loss from operations | -2,803 | -4,139 | -3,967 | |
| Interest and other expenses | - | - | 364 | |
| Interest and other income | 93 | 95 | 163 | |
| Change in fair value of warrant liabilities | -445 | 119 | 117 | |
| Other income (expense), net | 538 | -24 | -318 | |
| Loss from continuing operations | -2,265 | -4,163 | - | |
| Income (loss) from discontinued operations | - | -69 | - | |
| Net loss | -2,265 | -4,232 | -4,285 | |
| Net change in unrealized gain (loss) on available-for-sale securities, net of reclassification adjustments and taxes | - | - | 7 | |
| Total comprehensive loss | -2,265 | -4,232 | -4,278 | |
| Net loss per share - basic | -0.07 | -0.13 | -0.14 | |
| Net loss per share - diluted | -0.07 | -0.13 | -0.14 | |
| Weighted average number of shares outstanding - basic | 31,042,000 | 31,042,000 | 31,039,000 | |
| Weighted average shares used to compute diluted net loss per share | 31,163,000 | 31,042,000 | 31,039,000 | |